|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Rockefeller University Press,
0021-9525/2000//1009 $5.00
The Journal of Cell Biology, Volume 148, Number 5,
, 2000 1009-1020
Original Article |
Schwann Cell Myelination Requires Timely and Precise Targeting of P0 Protein
trappb{at}ccf.org
This report investigated mechanisms responsible for failed Schwann cell myelination in mice that overexpress P0 (P0tg), the major structural protein of PNS myelin. Quantitative ultrastructural immunocytochemistry established that P0 protein was mistargeted to abaxonal, periaxonal, and mesaxon membranes in P0tg Schwann cells with arrested myelination. The extracellular leaflets of P0-containing mesaxon membranes were closely apposed with periodicities of compact myelin. The myelin-associated glycoprotein was appropriately sorted in the Golgi apparatus and targeted to periaxonal membranes. In adult mice, occasional Schwann cells myelinated axons possibly with the aid of endocytic removal of mistargeted P0. These results indicate that P0 gene multiplication causes P0 mistargeting to mesaxon membranes, and through obligate P0 homophilic adhesion, renders these dynamic membranes inert and halts myelination.
Key Words: PNS myelination homophilic adhesion dysmyelination cell polarity myelin protein gene dosage
© 2000 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
Concomitant with the changes in periodicity of mesaxon membranes to compact myelin are molecular changes in the membranes. Periaxonal and mesaxon membranes are enriched in the myelin-associated glycoprotein (MAG), a type I transmembrane glycoprotein with five immunoglobulin-like domains and a molecular weight of
100 kD. MAG is not detected in compact myelin or the abaxonal membranes of myelinating Schwann cells (Trapp and Quarles 1982). P0 protein, the major structural protein of compact PNS myelin (Trapp et al. 1981) is another type I glycoprotein with a single immunoglobulin-like domain and molecular weight of 30 kD. While precise mechanisms by which mesaxon membranes convert to compact myelin are unknown, membrane insertion of P0 and its subsequent homophilic binding in both trans and cis orientations may exclude MAG and result in compact myelin formation (Heath et al. 1991; Shapiro et al. 1996). MAG and P0 are sorted into separate carrier vesicles as they exit the trans-Golgi network (Trapp et al. 1995). These vesicles are transported along the myelin internode in a microtubule (MT)-dependent manner, and then inserted directly into the appropriate membrane domain. This site-specific targeting of P0 and MAG plays an important role in establishing the polarity and expansion of Schwann cell membranes (Heath et al. 1991; Trapp et al. 1995).
Myelinating Schwann cells can synthesize several square millimeters of surface membranes. This requires high-level transcription of myelin protein genes and precisely regulated doses of translated proteins. Natural and induced myelin protein gene duplications cause dysmyelination and often more severe phenotypes than null mutations in the same gene, indicating the functional importance of appropriate myelin protein gene dosage during myelination. Proteolipid protein (PLP), an integral membrane protein with five membrane-spanning domains, is the major structural protein of CNS myelin (Lees and Brostoff 1984). Duplications in PLP cause Pelizaeus-Merzbacher disease (Hodes and Dlouhy 1996), an often fatal dysmyelinating condition of humans. PLP overexpression in transgenic mice also causes dysmyelination (Kagawa et al. 1994; Readhead et al. 1994). Peripheral myelin protein of 22 kD (PMP22) has four membrane-spanning domains and is enriched in PNS myelin (Snipes et al. 1992). Reciprocal unequal crossovers of a 1.5 megabase region of chromosome 17p11.2 causes allelic duplication or deletion of the PMP22 gene (Chance et al. 1994). Allelic duplication of 17p11.2 causes Charcot-Marie-Tooth Disease type 1A (CMT1A), a human peripheral neuropathy characterized by hypomyelination, demyelination/remyelination, onion bulb formation, and axonal atrophy (Lupski et al. 1991; Matsunami et al. 1992). Hereditary neuropathy with liability to pressure palsy (HNPP) is associated with allelic deletion of 17p11.2 (Chance et al. 1993). Alteration in PMP22 gene dosage in rodents also causes peripheral neuropathies (Magyar et al. 1996; Sereda et al. 1996) and supports altered PMP22 gene dosage as the causative factor in CMTIA and HNPP.
P0 gene duplication has not been associated with human peripheral neuropathies. P0 missense mutations, however, cause a variety of clinically defined human peripheral neuropathies including CMTIB, Dejerine-Sottas syndrome, and congenital hypomyelination (Warner et al. 1996). P0 null mutations in mice also cause dysmyelination (Giese et al. 1992). To investigate the potential consequence of increased P0 gene dosage, several lines of transgenic mice with extra copies of the mouse P0 gene were generated as described in Wrabetz et al. 2000(this issue). In this report, we have investigated the ultrastructural changes and mechanisms of dysmyelination in the line with highest P0 mRNA overexpression. Our studies indicate that P0 accumulates in inappropriate domains of the plasma membrane, blocking spiral mesaxon growth and preventing myelin formation.
| Materials and Methods |
|---|
|
|
|---|
Light and Electron Microscopic Analysis
Mice overexpressing P0 protein genes and littermate controls were examined at 2, 5, 14, 42, and 90 d of age. They were anesthetized with Metofane and perfused with 4% paraformaldehyde, 2.5% glutaraldehyde, and 0.08 M Sorenson's buffer. Sciatic nerves and lumbar ventral roots were removed, postfixed in osmium tetroxide, and embedded in Epon. For light microscopy, 1-µm thick sections of sciatic nerve were stained with toluidine blue and photographed with a Zeiss Axiophot microscope. For serial section analysis, series of 1-µm thick sections of lumbar ventral roots were mounted in order on slides and stained with toluidine blue. Areas of interest were digitally photographed using a Leica DMLB microscope fitted with an Optronics video camera and image acquisition system. Images were placed in order and aligned on separate layers in Adobe Photoshop 5 software. Profiles of interest were marked and followed by stepping through the layers.
For confocal microscopy, paraformaldehyde-fixed sciatic nerves from 25-d-old mice were teased and immunostained as described (Kidd et al. 1996). The teased fibers were imaged using a Leica TCS-NT confocal microscope.
For EM, thin sections were stained with uranyl acetate and lead citrate, and examined in a Philips CM100 electron microscope.
Electron Microscopic Immunocytochemistry
P0tg and age-matched wild-type (WT) mice at 5, 14, 42, and 90 d postnatal (three mice per time point) were anesthetized with Metofane and perfused with 2.5% glutaraldehyde, 4% paraformaldehyde, and 0.08 M Sorenson's buffer. The sciatic nerves and L4 ventral roots were removed, infiltrated with 2.3 M sucrose and 30% polyvinylpyrrolidone, placed on specimen stubs, and were then frozen in liquid nitrogen. Ultrathin cryosections (
120-nm thick) were cut on glass knives in a Reichart Ultracut S ultracryomicrotome (Leica Instruments) maintained at –110°C. The sections were placed on carbon- and Formvar-coated grids and immunostained by previously described immunogold procedures (Trapp et al. 1995).
Antibodies
Antibodies used in these studies are well characterized and include: polyclonals directed against P0 protein (Trapp et al. 1979, Trapp et al. 1981), and monoclonals directed against MAG (Doberson et al. 1985; Trapp et al. 1989, Trapp et al. 1995), neurofilaments (SMI 31 & 32; Sternberger Monoclonals Inc.), and acetylated
-tubulin (Sigma Chemical Co.). For quantitative immunogold labeling experiments, sections from WT and P0tg mice were stained in parallel.
Quantitative Analysis of Immunogold Labeling
Ultrathin cryosections were examined and photographed in a Philips CM-100 electron microscope. Digital images were captured from negatives. Gold particles over structures of interest were counted on screen, and areas and distances measured in NIH Image or Photoshop 5 software. Statistical analysis was performed by t test. Data are expressed as mean ± SEM. For P0 labeling of Schwann cell surface membranes, an average of 24 fibers was quantified at each age in both control and P0tg mice. These fibers were obtained from two control nerves and three P0tg nerves at each age. This analysis included 76 µm of periaxonal membrane (only 2 d analyzed) and 340 µm of abaxonal membrane in control, and 340 µm of periaxonal membrane and 476 µm of abaxonal membrane in P0tg cells. An average of 17 endosomes was analyzed at each age in P0tg mice. In control, 20 and 5 endosomes were analyzed at 5 and 14 d, respectively. Endosomes were not analyzed at 42 and 90 d in control nerves. 36 (control) and 27 (P0tg) Golgi apparatus were analyzed at 5 d, and 18 (control) and 35 (P0tg) Golgi apparatus at 42 d. The density of P0 staining over compact myelin was determined in 25 fibers from 42 d control and P0tg nerves. These fibers were obtained from three control and three P0tg nerves.
| Results |
|---|
|
|
|---|
P0 Distribution in P0tg Nerves
Most Schwann cells in P0tg nerves surrounded single axons or bundles of large diameter axons. To determine if these Schwann cells expressed P0, teased nerve fibers from 25 d P0tg nerves were stained with P0 antibodies and examined by confocal microscopy. Amyelinating Schwann cells surrounding single large diameter axons expressed abundant P0, had small cell bodies, and were closely spaced along individual axons (Fig. 1 A). P0 was detected in abaxonal and periaxonal regions of these cells and was concentrated in perikaryal cytoplasm. P0tg Schwann cells that surrounded bundles of axons also expressed abundant P0 (Fig. 1 B). This observation suggests that P0 overexpression impedes the sorting of axons into individual ensheathments.
|
EM analysis confirmed the phenotypes of failed axonal sorting and arrest of myelination in P0tg nerves (Fig. 2). At early stages of nerve development (five days), axons that failed to sort in one-to-one relationships were tightly bundled and totally or partially surrounded by Schwann cells (Fig. 2 A). A basal lamina often surrounded the outer perimeter of unensheathed regions of axon bundles, indicating former Schwann cell ensheathment. Myelin was not detected around axons in one-to-one relationships with Schwann cells, and occasionally individual Schwann cells were associated with two axons (Fig. 2 B). These phenotypes predominated in 90 d P0tg nerves (Fig. 2C and Fig. D). Many axons that failed to sort in one-to-one Schwann cell relationships had diameters in excess of 1 µm, and therefore should have been myelinated.
|
P0 Is Mistargeted in P0tg Schwann Cells
The correlation between extra copies of the P0 gene and arrest of myelination suggests that overexpression of P0 protein is responsible for the phenotype. To investigate this and elucidate the possible mechanism, the ultrastructural distribution of P0 protein was compared in ultrathin cryosections of control and P0tg nerves. In 2-d WT nerves, P0 antibodies labeled compact myelin, but not Schwann cell periaxonal, mesaxonal, or abaxonal membranes (Fig. 3 A). In P0tg nerves, however, intense P0 labeling of Schwann cell periaxonal, mesaxon, and abaxonal membranes was detected (Fig. 3 B). P0 labeling of axons and Schwann cell nuclei was rare in both control and P0tg nerves.
|
The possibility that Golgi membrane-associated P0 protein is increased in P0tg Schwann cells was investigated by quantifying the number of gold particles associated with Golgi membranes and their associated vesicles in 5 and 42 d control and P0tg Schwann cells with arrested myelination (Fig. 3 E). Gold particles were expressed per micrometer squared of Golgi apparatus area. At five days, there was a threefold increase in P0 gold particles (30.4 vs. 91.6) in P0tg Schwann cell Golgi membranes, when compared with five-day WT Golgi membranes. This difference was statistically significant (P < 0.0001). At 42 d, P0 labeling of control Schwann cell Golgi apparatus (35.1 gold particles/µm2) was similar to that at five days and
45% less (P < 0.01) than that found in 42 d P0tg Schwann cells (66.9 gold particles/µm2).
Some Schwann cells in P0tg nerves escaped the inhibition of myelination and formed compact myelin, suggesting that these cells may have established normal targeting pathways for P0. P0 labeling indices for the abaxonal membrane of these P0tg myelinating Schwann cells were identical (0.2 particles/µm) to age-matched WT fibers (Fig. 4A and Fig. B) and tenfold less than those detected in nonmyelinating P0tg Schwann cells in the same sections (Fig. 3C and Fig. D, Fig. 4 C). When P0 labeling over compact myelin was compared in controls (Fig. 4 D) and P0tg mice (Fig. 4 E), the labeling index was
40% higher for P0tg internodes (358 vs. 251 gold particles/µm2). This observation argues against the complete silencing of the P0 transgene in Schwann cells that myelinate in P0tg nerves.
|
|
80% of vesicles in P0tg Schwann cells contained only P0 gold particles (5 nm), 19% contained only MAG gold particles (10 nm), and 1–2% contained both MAG and P0 (5- and 10-nm gold particles). In both control and P0tg Schwann cells,
65% of the P0-labeled vesicles contained more than one gold particle. These data indicate that MAG and P0 are appropriately sorted into separate carrier vesicles as they exit the trans-Golgi network of P0tg Schwann cells with arrested myelination.
P0 Is Abnormally Enriched in Endosomes in P0tg Schwann Cells
Abundant P0 labeling of transport vesicles and normal appearance of RER and Golgi membranes suggested that P0 protein was appropriately synthesized and processed in P0tg Schwann cells with arrested myelination. However, P0 labeling indices of Schwann cell surface membranes remained relatively constant between 14 and 42 d (Fig. 3C and Fig. D). These observations suggest a rapid turnover of P0 from P0tg Schwann cell surface membranes, possibly by endocytosis and P0 degradation through the endosomal/lysosomal system. This hypothesis was tested by comparing the density of gold particles over endosomes in P0-stained cryosection from control and P0tg Schwann cells at 5, 14, 42, and 90 d (Fig. 6). At five days, endosomes were prominent in P0tg Schwann cells with arrested myelination (Fig. 6 B). Endosomes were less conspicuous in control Schwann cells (Fig. 6 A). Quantification of P0 labeling detected 10 gold particles/µm2 of endosomal area in control Schwann cells. In contrast, P0tg Schwann cells contain 191 gold particles/µm2 of endosome area. At 14 d, endosomes in P0tg Schwann cells contained 129 gold particles/µm2, compared with 12 gold particles/µm2 in control Schwann cells. At 42 and 90 d, endosomes in P0tg Schwann cells contains 152 and 101 gold particles/µm2. Endosomes were rare in control Schwann cells of the same ages and, when present, contained >1 gold particle/µm2. These data are consistent with continuous removal of mistargeted P0 in P0tg Schwann cells with arrested myelination.
|
|
| Discussion |
|---|
|
|
|---|
Specificity of Phenotype
Axon–Schwann cell interactions and signaling are bidirectional and mediated by physical contact. Unidentified axonal signals initiate a myelinating genome in Schwann cells and axonal contact is essential for myelin formation (Aguayo et al. 1976; Weinberg and Spencer 1976). Schwann cells in turn provide an extrinsic trophic effect for maturation of the axon (Windebank et al. 1985; deWaegh et al. 1992; Hsieh et al. 1994; Sanchez et al. 1996; Yin et al. 1998). Individual axons in P0tg mice can be myelinated, surrounded by a Schwann cell with arrested myelination, or part of an axonal bundle (Fig. 1 E). These observations and the rescue of the P0tg phenotype through breeding to P0 null mice (Wrabetz et al. 2000, this issue) are most consistent with a primary Schwann cell defect in P0tg mice. While extensive analysis of axonal diameters has yet to be performed, axonal diameters increase in the P0tg nerves regardless of the Schwann cell state of differentiation. Schwann cells in one-to-one associations with axons contained MAG, a molecule previously demonstrated to influence axonal maturation by increasing the phosphorylation state and spacing of neurofilaments (Yin et al. 1998).
P0 Overexpression Causes a Unique Phenotype
Myelin protein overexpression causes a variety of phenotypes in mice. Whereas Schwann cells overexpressing P0 share some similarities with Schwann cells overexpressing other myelin proteins, the phenotype of failed axonal sorting and arrest of myelination at early mesaxon formation is unique. The P0tg phenotype differs from that produced by the toxic accumulation of overexpressed PLP in the Golgi apparatus and RER (Kagawa et al. 1994; Readhead et al. 1994). Schwann cell death and abnormal RER and Golgi networks were not observed in P0tg nerves. Processing and folding the four membrane-spanning PLP in the RER and Golgi apparatus may represent a greater challenge than the processing of the single membrane spanning P0 protein. Transgenic mice with extra copies of PMP22 genes display progressive neurological phenotypes and peripheral nerve pathology that correlate with copy number (Magyar et al. 1996; Sereda et al. 1996). At higher doses, Schwann cells sorted axons in one-to-one relationships, formed a normal basal lamina, rarely formed myelin, but had normal mesaxon membrane spacing. Although the function of PMP22 is unknown, the mechanisms responsible for arrest of myelination in PMP22 overexpressing mice are likely to differ significantly from those in P0tg mice.
2',3' cyclic nucleotide 3'-phosphodiesterase (CNP) is an extrinsic membrane protein that associates with the cytoplasmic side of oligodendrocyte and Schwann cell surface membranes, but is normally excluded from compact myelin (Yin et al. 1997; Braun et al. 1988; Trapp et al. 1988). In transgenic mice with a sixfold increase in CNP levels (Gravel et al. 1996; Yin et al. 1997), oligodendrocytes spirally wrapped axons, but often failed to form MDL. CNP was mistargeted to the cytoplasmic leaflet of these myelin membranes and prevented normal accumulation of myelin basic protein (Yin et al. 1997), a molecular requirement of MDL formation in the CNS (Privat et al. 1979; Roach et al. 1983). These observations provide another example of mistargeting of a myelin-related protein due to overexpression and indicate protein-specific phenotypes as a result of the molecular properties of the overexpressed proteins.
Mechanism of P0 Targeting
Much of what is known about mechanisms of protein sorting and targeting has been obtained from in vitro studies of epithelial cells that polarize their surfaces into apical and basolateral domains (Rodriguez-Boulan and Nelson 1989; Simons and Wandinger-Ness 1990; Mostov et al. 1992; Weimbs et al. 1997). Proteins are targeted to appropriate domains by direct or indirect pathways (Rindler et al. 1984; Hubbard and Stieger 1989). Previous studies support direct delivery of P0 protein to compact myelin in an MT-dependent manner (Trapp et al. 1995; Kidd et al. 1996). In the present study, P0 protein was detected on all surface membranes of P0tg Schwann cells, indicating that P0 is synthesized and transported, but not appropriately targeted. The distributions of Golgi apparatus, intermediate filaments, RER, and smooth ER are maintained by MTs (Trapp et al. 1995) and appeared unaltered in P0tg Schwann cells. Based on these observations, it is unlikely that P0 mistargeting results from abnormal MT distribution or function.
P0tg Schwann cells in one-to-one relationship with axons appropriately ensheath axons, target MAG to periaxonal membranes, and form a basal lamina on their abaxonal membrane. Thus, a significant degree of membrane polarization and appropriate protein targeting occurs in the presence of P0 overexpression. Site-specific targeting of membrane proteins occurs via a variety of mechanisms including sorting into specific transport vesicles in the Golgi apparatus, site-specific intracellular vesicular transport, site-specific vesicle docking or fusion, inhibition of vesicle docking or fusion, and stabilization of proteins within discrete membrane domains (Weimbs et al. 1997; Allan and Balch 1999). Whereas our data indicated normal sorting of P0 and MAG in the trans-Golgi network, we cannot rule out the possibility that excessive P0 is missorted into vesicles destined for membranes other than compact myelin. P0 labeling of Golgi membranes was increased in P0tg Schwann cells. P0 did not accumulate in the Golgi apparatus with age, however, and Golgi membranes appeared normal in electron micrographs. These observations support normal synthesis and processing of P0 to the carrier vesicle stage. In addition, when carrier vesicle transport is halted in myelinating Schwann cells by MT disruption, P0-enriched carrier vesicles accumulated in perinuclear cytoplasm and fused to form compact myelin-like membranes (Trapp et al. 1995). Such membranes were not abundant in P0tg Schwann cells cytoplasm, supporting targeting of P0 to surface membranes.
Whereas our data supports interpretations regarding the synthesis, sorting, and targeting of P0, they are based on static images of P0 distribution. Pulse–chase experiments of P0 synthesis and degradation would be essential to establish the role of the endosomal system in P0 targeting (Gu and Gruenberg 1999; Marsh and McMahon 1999). While the interpretation that mistargeted P0 is removed from membranes by endocytosis is supported by the close proximity of P0-labeled endosomes to abaxonal membranes, it is possible that overexpressed P0 is also directly targeted to the endosomal/lysosomal system. In either case, the absence of significant amounts of P0 in endosomes during normal myelination supports the general conclusion that P0 overexpression results in P0 accumulation in endosomes.
P0 Homophilic Binding Inhibits Mesaxon Expansion
During normal myelination, P0 has been detected in compact myelin, but not mesaxon membranes. As mesaxon membranes convert to compact myelin, however, P0 is likely to be transiently present in MAG-positive mesaxon membranes at levels not detected by current techniques. In P0tg mesaxon membranes, levels of P0 reached the threshold for detection and trans adhesion during their initial wrap. Arrest of myelination may result from simple overexpression of P0 in mesaxon membranes, where it is normally expressed at low undetectable levels on its way to the expanding myelin sheath, or by early expression and mistargeting to mesaxon membranes before establishment of migratory machinery. P0-mediated trans adhesion at 2.5 nm also requires exclusion of molecules with large extracellular domains. MAG (Fig. 5A and Fig. C) and P0 (Fig. 3B and Fig. D) were detected in the periaxonal membrane of P0tg Schwann cells that apposed the P0-negative axolemma by 12–14 nm (Fig. 7). The abaxonal membrane of most P0tg Schwann cells contained significant levels of P0 and a normal appearing basal lamina. The presence of P0 in a single membrane, therefore, does not exclude other proteins with large extracellular domains. However, when P0-positive mesaxon or abaxonal membranes apposed each other, MAG and the basal lamina were excluded, resulting in close apposition (2.5 nm; Fig. 7). In addition, P0 transfection in nonadherent cells in vitro induced obligate adhesion of apposing plasma membranes, reorganization of submembranous cytoskeleton, and junctional complexes at the transition between adherent and nonadherent membrane domains (D'Urso et al. 1990; Filbin et al. 1990). Liquid crystallography at 1.9 Å resolution supports emanation of the extracellular domain of P0 as cis-linked tetramers that bind to P0 tetramers in opposite orientation on the apposing membrane surface (Shapiro et al. 1996). Collectively, these data support the possibility that arrest of myelination in P0tg mice is caused by early trans-P0 tetramer binding of the initial mesaxon wrap. This trans-P0 binding induces cis-P0 tetramer binding, which then excludes molecules responsible for spiral wrapping of mesaxon membranes.
| Acknowledgments |
|---|
This work was supported by the National Institutes of Health grants NS-38186 (to B.D. Trapp) and NS-23375 (to A. Messing), by Telethon Italy (L. Wrabetz and M.L. Feltri), European Community Biomed Program (L. Wrabetz), and Fondazione Giovanni Armenise-Harvard (L. Wrabetz and M.L. Feltri).
Submitted: 19 October 1999
Revised: 12 January 2000
Accepted: 24 January 2000
Abbreviations used in this paper: CMT1A, Charcot-Marie-Tooth disease type 1A; CMT1B, Charcot-Marie-Tooth disease type 1B; CNP, 2',3' cyclic nucleotide 3'-phosphodiesterase; MAG, myelin-associated glycoprotein; MDL, major dense line; MT, microtubule; P0tg, TgN22Mes transgenic mice overexpressing P0 proteins; PLP, proteolipid protein; PMP22, peripheral myelin protein 22 kD; WT, wild-type.
| References |
|---|
|
|
|---|
Aguayo A.J. Epps J. Charron L. Bray G.M. Multipotentiality of Schwann cells in cross anastomosed and grafted myelinated and unmyelinated nervesquantitative microscopy and radioautography, Brain Res. 104, 1976 1–20.[Medline]
Allan B.B. Balch W.E. Protein sorting by directed maturation of Golgi compartments, Science. 285, 1999 63–66.
Braun P.E. Sandillon F. Edwards A. Matthieu J.-M. Privat A. Immunocytochemical localization by electron microscopy of 2',3'-cyclic nucleotide 3'-phosphodiesterase in developing oligodendrocytes of normal and mutant brain, J. Neurosci. 8, 1988 3057–3066.[Abstract]
Chance P.F. Alderson M.K. Leppig K.A. Lensch M.W. Matsunami N. Smith B. Swanson P.D. Odelberg S.J. Disteche C.M. Bird T.D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies, Cell. 72, 1993 143–151.[Medline]
Chance P.F. Abbas N. Lensch M.W. Pentao L. Roa B.B. Patel P.I. Lupski J.R. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17, Hum. Mol. Gen. 3, 1994 223–228.
D'Urso D. Brophy P.J. Staugaitis S.M. Gillespie C.S. Frey A.B. Stempak J.G. Colman D.R. Protein zero of peripheral nerve myelinbiosynthesis, membrane insertion, and evidence for homotypic interaction, Neuron. 2, 1990 449–460.[Medline]
deWaegh S.M. Lee V.M.Y. Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells, Cell. 68, 1992 451–463.[Medline]
Doberson M.G. Hammer J.K. Noronha A.B. MacIntosch T.D. Trapp B.D. Brady R.O. Quarles R.H. Generation and characterization of mouse monoclonal antibodies to the myelin-associated glycoprotein (MAG), Neurochem. Res. 10, 1985 423–437.
Feltri M.L. D'antonio M. Quattrini A. Numerato R. Arona M. Previtali S. Chiu S.Y. Messing A. Wrabetz L. A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells, Eur. J. Neurosci. 11, 1999 1577–1586.[Medline]
Filbin M.T. Walsh F.S. Trapp B.D. Pizzey J.A. Tennekoon G.I. The role of myelin P0 protein as a homophilic adhesion molecule, Nature. 344, 1990 871–872.[Medline]
Giese K.P. Martini R. Lemke G. Soriano P. Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons, Cell. 71, 1992 565–576.[Medline]
Gravel M. Peterson J. Yong V.W. Kottis V. Trapp B. Braun P.E. Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination, Mol. Cell. Neurosci. 7, 1996 453–466.[Medline]
Gu F. Gruenberg J. Biogenesis of transport intermediates in the endocytic pathway, FEBS Lett. 452, 1999 61–66.[Medline]
Heath J.W. Inuzuka T. Quarles R.H. Trapp B.D. Distribution of P0 protein and the myelin-associated glycoprotein in peripheral nerves from Trembler mice, J. Neurocytol. 20, 1991 439–449.[Medline]
Hodes M.E. Dlouhy S.R. The proteolipid protein genedouble, double, ... and trouble, Am. J. Hum. Genet. 59, 1996 12–15.[Medline]
Hsieh S.-T. Kidd G.J. Crawford T.O. Xu Z. Trapp B.D. Cleveland D.W. Griffin J.W. Regional modulation of neurofilament organization by myelination in normal axons, J. Neurosci. 14, 1994 6392–6401.[Abstract]
Hubbard A.L. Stieger B. Biogenesis of endogenous plasma membrane proteins in epithelial cells, Annu. Rev. Physiol. 51, 1989 755–770.[Medline]
Kagawa T. Ikenaka K. Inoue Y. Kuriyama S. Tsujii T. Nakao J. Nakajima K. Aruga J. Okano H. Mikoshiba K. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene, Neuron. 13, 1994 427–442.[Medline]
Kidd G.J. Andrews S.B. Trapp B.D. Axons regulate the distribution of Schwann cell microtubules, J. Neurosci. 16, 1996 946–954.
Lees M.B. Brostoff S.W. Proteins of myelin, Morrell P.. Myelin, 1984 197–224 Plenum Press New York.
Lupski J.R. Montes de Oca-Luna R. Slaugenhaupt S. Pentao L. Guzzetta V. Trask B.J. Saucedo-Cardenas O. Barker D.F. Killian J.M. Garcia C.A. DNA duplication associated with Charcot-Marie-Tooth disease type 1A, Cell. 66, 1991 219–232.[Medline]
Magyar J.P. Martini R. Ruelicke T. Aguzzi A. Adlkofer K. Dembic Z. Zielasek J. Toyka K.V. Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage, J. Neurosci. 16, 1996 5351–5360.
Marsh M. McMahon H.T. The structural era of endocytosis, Science. 285, 1999 215–220.
Matsunami N. Smith B. Ballard L. Lensch M.W. Robertson M. Albertsen H. Hanemann C.O. Müller H.W. Bird T.D. White R. Chance P.F. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A, Nature Gen. 1, 1992 176–179.[Medline]
Mostov K. Apodaca G. Aroeti B. Okamoto C. Plasma membrane protein sorting in polarized epithelial cells, J. Cell Biol. 116, 1992 577–583.
Peters A. Palay S.L. Webster H.d., The Fine Structure of the Nervous SystemNeurons and their Supporting Cells, 1991 Oxford University Press New York.
Privat A. Jacque C. Bourre J.M. Duponey P. Baumann N. Absence of the major dense line in myelin of the mutant mouse "Shiverer", Neurosci. Lett. 12, 1979 107–112.[Medline]
Readhead C. Schneider A. Griffiths I. Nave K.-A. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage, Neuron. 12, 1994 583–595.[Medline]
Rindler M.J. Ivanov I.E. Plesken H. Rodriguez-Boulan E. Sabatini D.D. Viral glycoproteins destined for apical or basolateral plasma membrane domains transverse the same Golgi apparatus during their intracellular transport in Madin-Darby canine kidney cells, J. Cell Biol. 98, 1984 1304–1319.
Roach A. Boylan K.B. Horvath S. Prusiner S.B. Hood L.E. Characterization of cloned cDNA representing rat myelin basic proteinabsence of expression in brain of shiverer mutant mice, Cell. 34, 1983 799–806.[Medline]
Rodriguez-Boulan E. Nelson W.J. Morphogenesis of the polarized epithelial cell phenotype, Science. 245, 1989 718–725.
Sanchez I. Hassinger L. Paskevich P.A. Shine H.D. Nixon R.A. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation, J. Neurosci. 16, 1996 5095–5105.
Sereda M. Griffiths I. Pühlhofer A. Stewart H. Rossner M.J. Zimmermann F. Magyar J.P. Schnieder A. Hund E. Meinck H.-M. A transgenic rat model of Charcot-Marie-Tooth disease, Neuron. 16, 1996 1049–1060.[Medline]
Shapiro L. Doyle J.P. Hensley P. Colman D.R. Hendrickson W.A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin, Neuron. 17, 1996 435–449.[Medline]
Simons K. Wandinger-Ness A. Polarized sorting in epithelia, Cell. 62, 1990 207–210.[Medline]
Snipes G.J. Suter U. Welcher A.A. Shooter E.M. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13), J. Cell Biol. 117, 1992 225–238.
Trapp B.D. Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in Quaking mouse peripheral nerve, J. Cell Biol. 107, 1988 675–685.
Trapp B.D. Quarles R.H. Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin, J. Cell Biol. 92, 1982 877–882.
Trapp B.D. McIntyre L.J. Quarles R.H. Sternberger N.H. Webster H.d. Immunocytochemical localization of rat peripheral nervous system myelin proteinsP2 protein is not a component of all peripheral nervous system myelin sheaths, Proc. Natl. Acad. Sci. USA. 76, 1979 3552–3556.
Trapp B.D. Itoyama Y. Sternberger N.H. Quarles R.H. Webster H.d. Immunocytochemical localization of P0 protein in Golgi complex membranes and myelin of developing rat Schwann cells, J. Cell Biol. 90, 1981 1–6.
Trapp B.D. Bernier L. Andrews S.B. Colman D.R. Cellular and subcellular distribution of 2',3' cyclic nucleotide 3' phosphodiesterase and its mRNA in the rat nervous system, J. Neurochem. 51, 1988 859–868.[Medline]
Trapp B.D. Andrews S.B. Cootauco C. Quarles R.H. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes, J. Cell Biol. 109, 1989 2417–2426.
Trapp B.D. Kidd G.J. Hauer P.E. Mulrenin E. Haney C. Andrews S.B. Polarization of myelinating Schwann cell surface membranesrole of microtubules and the trans-Golgi network, J. Neurosci. 15, 1995 1797–1807.[Abstract]
Warner L.E. Hilz M.J. Appel S.H. Killian J.M. Kolodny E.H. Karpati G. Carpenter S. Watters G.V. Wheeler C. Witt D. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination, Neuron. 17, 1996 451–460.[Medline]
Weimbs T. Low S.H. Chapin S.J. Mostov K.E. Apical targeting in polarized epithelial cellsthere's more afloat than rafts, Trends Cell Biol. 7, 1997 393–399.[Medline]
Weinberg H.J. Spencer P.S. Studies on the control of myelinogenesis. II. Evidence for neuronal regulation of myelin production, Brain Res. 113, 1976 363–378.[Medline]
Windebank A.J. Word P. Bunge R.P. Dyck P.J. Myelination determines the caliber of dorsal root ganglion neurons in culture, J. Neurosci. 6, 1985 1563–1567.[Medline]
Wrabetz L. Feltri M.L. Quattrini A. Imperiale D. Previtali S. D'Antonio M. Martini R. Yin X. Trapp B.D. Xhou L. P0 overexpression causes congenital hypomyelination of peripheral nerves, J. Cell Biol. 148, 2000 1021–1033.
Yin X. Peterson J. Gravel M. Braun P.E. Trapp B.D. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction, J. Neurosci. Res. 50, 1997 238–247.[Medline]
Yin X. Crawford T.O. Griffin J.W. Tu P.-H. Lee V.M.Y. Li C. Roder J. Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons, J. Neurosci. 18, 1998 1953–1962.
Related Article
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|